UroBrussels
ActiveUroBrussels has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €236k and a net result of €116k. Equity is growing by ~54.2% per year across the filed fiscal years. Its solvency ranks better than 88% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22k at 30 days acceptable
Liquidity ample (current ratio 14.86 against 7.02 in 2024; short-term debt: 6.6% and cash: 77.3% of total assets), and 6.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
93.4%
Return on assets
46.1%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
1 d early
2024
2 d early
2023
1 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close22-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€236k▲ 60.4%
2024 · €147k
2023: €76k
2024: €147k
2023 → 2025
Total assets
€252k▲ 48.4%
2024 · €170k
2023: €94k
2024: €170k
2023 → 2025
Net result
€116k▲ 17.4%
2024 · €99k
2023: €73k
2024: €99k
2023 → 2025
Working capital
€229k▲ 65.3%
2024 · €139k
2023: €64k
2024: €139k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€76k-€147k▲ 92.3%€236k▲ 60.4%
Operating result€105k-€138k▲ 31.8%€151k▲ 9.1%
Net result€73k-€99k▲ 35.0%€116k▲ 17.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 9% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €252k
Fixed assets
€6k▼ 23.0%
Current assets
€246k▲ 52.0%
Equity and liabilities €252k
Equity
€236k▲ 60.4%
Debt
€17k▼ 28.1%
The debt ratio falls from 13.5% to 6.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€156k▲
2024 · €147k
Cash flow
€121k▲
2024 · €107k
Solvency
93.4%▲
2024 · 86.5%
Current ratio
14.86▲
2024 · 7.02
Quick ratio
14.86▲
2024 · 7.02
Debt / equity
0.07▼
2024 · 0.16
ROE
49.4%▼
2024 · 67.5%
ROA
46.1%▼
2024 · 58.3%
Interest coverage
141.84▲
2024 · 120.77
Debt
€17k▼
2024 · €23k
Debt ≤ 1 year
€17k▼
2024 · €23k
Income taxes
€34k▼
2024 · €38k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€170k€252k▲
Fixed assets21/28€8k€6k▼
Tangible fixed assets22/27€8k€6k▼
Furniture and vehicles24€7k€5k▼
Other tangible fixed assets26€2k€1k▼
Current assets29/58€162k€246k▲
Amounts receivable within one year40/41€2k-
Trade receivables40€31-
Other amounts receivable41€2k-
Cash at bank and in hand54/58€93k€195k▲
Deferred charges and accrued income490/1€67k€51k▼
Equity and liabilities
Total equity and liabilities10/49€170k€252k▲
Equity10/15€147k€236k▲
Contributions10/11€3k€3k=
Reserves13€144k€233k▲
Distributable reserves133€144k€233k▲
Amounts payable17/49€23k€17k▼
Amounts payable within one year42/48€23k€17k▼
Trade debts44€168€378▲
Suppliers440/4€168€378▲
Taxes, remuneration and social security45€23k€16k▼
Taxes450/3€23k€16k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€5k▼
Other operating charges640/8€91€49▼
Non-recurring operating charges66A-€513
Gross operating margin9900€147k€156k▲
Operating profit (loss)9901€138k€151k▲
Financial income75/76B€301€669▲
Recurring financial income75€301€669▲
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€137k€150k▲
Income taxes67/77€38k€34k▼
Profit (loss) for the period9904€99k€116k▲
Profit (loss) for the period to be appropriated9905€99k€116k▲
Appropriation of the result
Profit (loss) to be appropriated9906€99k€116k▲
Transfer to equity691/2€70k€89k▲
To other reserves6921€70k€89k▲
Profit to be distributed694/7€29k€28k▼
Return on contributions (dividend)694€29k€28k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Highest result since 2023net €116k ▲17.4%
Operating result €151k, net result €116k, both a record.
30-06
Financial
Liquidity doublescurrent ratio 14.86
Current ratio from 7.02 to 14.86; short-term debt falls from €23k to €17k.
30-06
Financial
Equity above €200kEq €236k ▲60.4%
3 profitable years in a row build equity to €236k.
29-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Equity above €100kEq €147k ▲92.3%
2 profitable years in a row build equity to €147k.
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Etterbeek · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Beckersstraat 4C1040 EtterbeekGround area
2,745 m²
Building footprint
1,971 m²
Volume, LiDAR
25,172 m³
Parcel 21363B0391/00T012, Brussels · tallest building 18.6 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Uro Brussels
since 20222.332.358.565
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21363B0391/00T012 | Brussels | 2,745 m² | 1 · 1,970 m² | 18.6 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. BART DENYS Internist-Nefroloog
BE 0643.556.396
Deinze · Eq €236k
DOCTEUR JEAN-MICHEL MINE
BE 0863.852.603
Charleroi · Eq €236k
Labo Kris Mervillie
BE 0552.857.438
Nazareth-De Pinte · Eq €236k
Dr. Sofie Van Renterghem Pathologische anatomie
BE 0734.956.429
Gent · Eq €235k
Docteur Niemants Medical
BE 0543.625.612
Genappe · Eq €236k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,666 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded16-05-2022
Fiscal year end30-06
Activities, NACEBEL
86220Specialist medical practice
85699Other educational support services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.